1256768-46-3Relevant academic research and scientific papers
Benzothiadiazide derivative, preparation method and application thereof
-
Paragraph 0394; 0395; 0396; 0397, (2017/10/13)
The invention provides a compound with a structure shown as formula (I) and a preparation method thereof. The invention also provides an application of the compound in preventing and treating diabetic complication and a drug composition containing the com
Acetic acid derivatives of 3,4-dihydro-2 H-1,2,4-benzothiadiazine 1,1-dioxide as a novel class of potent aldose reductase inhibitors
Chen, Xin,Zhu, Changjin,Guo, Fan,Qiu, Xiaowei,Yang, Yanchun,Zhang, Shuzhen,He, Minlan,Parveen, Shagufta,Jing, Chaojun,Li, Yan,Ma, Bing
experimental part, p. 8330 - 8344 (2011/02/23)
A series of novel benzothiadiazine 1,1-dioxide derivatives were synthesized and tested for their inhibitory activity against aldose reductase. Of these derivatives, 17 compounds, having a substituted N2-benzyl group and a N4-acetic acid group on the benzothiadiazine, were found to be potent and selective aldose reductase inhibitors in vitro with IC50 values ranging from 0.032 to 0.975 μM. 9m proved to be the most active in vitro. The eight top-scoring compounds coming from the in vitro test for ALR2 inhibition activity were then tested in vivo, whereby three derivatives, 9i, 9j, and 9m, demonstrated a significantly preventive effect on sorbitol accumulation in the sciatic nerve in the 5-day streptozotocin-induced diabetic rats in vivo. Structure-activity relationship and molecular docking studies highlighted the importance of substitution features of N4-acetic acid group and halogen-substituted N2-benzyl group in the benzothiadiazine scaffold and indicated that substitution with hallogen at C-7 had a remarkably strong effect on ALR2 inhibition potency.
